Lanxess AG
General ticker "LNXSF" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $1.8B (TTM average)
Lanxess AG does not follow the US Stock Market performance with the rate: -20.5%.
Estimated limits based on current volatility of 0.1%: low 17.18$, high 17.20$
Factors to consider:
- Company pays dividends (annually): last record date 2026-05-25, amount 0.12$ (Y0.70%)
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [11.97$, 24.48$]
- 2026-12-31 to 2027-12-31 estimated range: [13.09$, 25.61$]
Financial Metrics affecting the LNXSF estimates:
- Positive: with PPE of 25.3 at the end of fiscal year the price was neutral
- Positive: 15.29 < Operating cash flow per share per price, % of 17.72
- Negative: Industry operating cash flow per share per price (median), % of 5.08 <= 5.56
- Positive: -13.52 < Operating profit margin, % of -0.60
- Negative: negative Net income
- Negative: -0.33 < Industry inventory ratio change (median), % of -0.11
- Positive: 42.26 < Shareholder equity ratio, % of 43.22 <= 49.86
- Negative: 2.54 < Interest expense per share per price, % of 2.96
- Negative: 0 < Inventory ratio change, % of 0.30
Short-term LNXSF quotes
Long-term LNXSF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €6,714.00MM | €6,366.00MM | €5,670.88MM |
| Operating Expenses | €7,382.00MM | €6,394.00MM | €5,704.86MM |
| Operating Income | €-668.00MM | €-28.00MM | €-33.99MM |
| Non-Operating Income | €-279.00MM | €-169.00MM | €-436.84MM |
| Interest Expense | €96.00MM | €48.66MM | €43.98MM |
| R&D Expense | €99.00MM | €104.00MM | €95.96MM |
| Income(Loss) | €-947.00MM | €-197.00MM | €-470.82MM |
| Taxes | €-105.00MM | €-21.00MM | €104.96MM |
| Net Income(Loss)* | €443.00MM | €-177.00MM | €-576.78MM |
| Stockholders Equity | €4,501.00MM | €4,586.00MM | €3,493.69MM |
| Inventory | €1,360.00MM | €1,348.00MM | €1,220.54MM |
| Assets | €9,665.00MM | €9,711.00MM | €8,083.97MM |
| Operating Cash Flow | €838.00MM | €508.00MM | €262.90MM |
| Capital expenditure | €326.00MM | €320.00MM | €318.88MM |
| Investing Cash Flow | €423.00MM | €-263.00MM | €388.85MM |
| Financing Cash Flow | €-1,466.00MM | €-97.00MM | €-517.81MM |
| Earnings Per Share** | €5.13 | €-2.05 | €-6.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.